{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:22:02Z","timestamp":1791400922927,"version":"4.3.3"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.intimp.2015.12.011","type":"journal-article","created":{"date-parts":[[2015,12,19]],"date-time":"2015-12-19T05:48:26Z","timestamp":1450504106000},"page":"105-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Role of interleukin-23 as a biomarker in rheumatoid arthritis patients and its correlation with disease activity"],"prefix":"10.1016","volume":"31","author":[{"given":"Doaa S.E.","family":"Zaky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eslam M.A.","family":"El-Nahrery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2015.12.011_bb0005","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","article-title":"Rheumatoid arthritis","volume":"376","author":"Scott","year":"2010","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.intimp.2015.12.011_bb0010","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2174\/187152812800392805","article-title":"The IL-23\/Th17 pathway as a therapeutic target in chronic inflammatory diseases","volume":"11","author":"Toussirot","year":"2012","journal-title":"Inflamm. Allergy Drug Targets"},{"issue":"2","key":"10.1016\/j.intimp.2015.12.011_bb0015","first-page":"165","article-title":"New insights into the pathogenesis of cutaneous autoimmune disorders","volume":"26","author":"Chiricozzi","year":"2012","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.intimp.2015.12.011_bb0020","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation","volume":"201","author":"Langrish","year":"2005","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.intimp.2015.12.011_bb0025","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.21749","article-title":"Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort)","volume":"54","author":"Kirkham","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2015.12.011_bb0030","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1084\/jem.20061775","article-title":"Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction.","volume":"203","author":"Sato","year":"2006","journal-title":"J. Exp. Med."},{"issue":"10","key":"10.1016\/j.intimp.2015.12.011_bb0035","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/ard.61.10.870","article-title":"Interleukin 17 synergises with tumour necrosis factor alpha to induce cartilage destruction in vitro","volume":"61","author":"Van Bezooijen","year":"2002","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2015.12.011_bb0040","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/ar1478","article-title":"Review the role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models","volume":"7","author":"Lubberts","year":"2005","journal-title":"Arthritis Res. Ther."},{"issue":"11","key":"10.1016\/j.intimp.2015.12.011_bb0045","first-page":"2403","article-title":"Monocyte derived interleukin (IL)-23 is an important determinant of synovial IL-17A expression in rheumatoid arthritis","volume":"36","author":"Stamp","year":"2009","journal-title":"J. Rheol."},{"issue":"3","key":"10.1016\/j.intimp.2015.12.011_bb0050","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1365-3083.2009.02361.x","article-title":"IL-23 in the pathogenesis of rheumatoid arthritis","volume":"71","author":"Paradowska-Gorycka","year":"2010","journal-title":"Scand. J. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2015.12.011_bb0055","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/acr.21641","article-title":"Review 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis","volume":"64","author":"Singh","year":"2012","journal-title":"Arthritis Care Res."},{"issue":"1","key":"10.1016\/j.intimp.2015.12.011_bb0060","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"Prevoo","year":"1995","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2015.12.011_bb0065","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00000441-193101000-00002","volume":"181","author":"Cecil","year":"1931","journal-title":"Am. J. Med Sci."},{"key":"10.1016\/j.intimp.2015.12.011_bb0070","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0002-9343(50)90226-9","volume":"8","author":"Anderson","year":"1950","journal-title":"Am. J. Med."},{"key":"10.1016\/j.intimp.2015.12.011_bb0075","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00005-007-0032-8","article-title":"The function of interleukin 17 in the pathogenesis of rheumatoid arthritis","volume":"55","author":"Paradowska","year":"2007","journal-title":"Arch. Immunol. Ther. Exp."},{"issue":"4","key":"10.1016\/j.intimp.2015.12.011_bb0080","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni0407-345","article-title":"Review T(H)-17 cells in the circle of immunity and autoimmunity","volume":"8","author":"Bettelli","year":"2007","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2015.12.011_bb0085","first-page":"452","article-title":"The IL-12\/IL-23 axis and its role in Th17 cell development, pathology and plasticity in arthritis","volume":"10","author":"Cornelissen","year":"2009","journal-title":"Curr. Opin. Investig. Drugs"},{"issue":"7","key":"10.1016\/j.intimp.2015.12.011_bb0090","first-page":"337","article-title":"Interleukin-23 and its correlation with disease activity, joint damage, and -functional disability in rheumatoid arthritis. Kaohsiung","volume":"30","author":"Dalila","year":"2014","journal-title":"J. Med. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2015.12.011_bb0095","doi-asserted-by":"crossref","first-page":"850","DOI":"10.3760\/cma.j.issn.0366-6999.20113093","article-title":"Increased interleukin-23 is associated with increased disease activity in patients with rheumatoid arthritis","volume":"126","author":"Guo","year":"2013","journal-title":"Chin. Med. J."},{"issue":"3","key":"10.1016\/j.intimp.2015.12.011_bb0100","doi-asserted-by":"crossref","first-page":"e0119981","DOI":"10.1371\/journal.pone.0119981","article-title":"Dysregulated serum IL-23 and SIRT1 activity in peripheral blood mononuclear cells of patients with rheumatoid arthritis","volume":"10","author":"Wendling","year":"2015","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.intimp.2015.12.011_bb0105","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3343\/alm.2013.33.1.52","article-title":"Elevated levels of T helper 17 cells are associated with disease activity in patients with rheumatoid arthritis","volume":"33","author":"Kim","year":"2013","journal-title":"Ann. Lab. Med."},{"issue":"4","key":"10.1016\/j.intimp.2015.12.011_bb0120","doi-asserted-by":"crossref","first-page":"R126","DOI":"10.1186\/ar3431","article-title":"Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-\u03b1 therapy","volume":"13","author":"Chen","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2015.12.011_bb0125","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00296-007-0388-4","article-title":"Etanercept reduces the serum levels of interleukin-23 and macrophage inflammatory protein-3 alpha in patients with rheumatoid arthritis","volume":"28","author":"Kageyama","year":"2007","journal-title":"Rheumatol. Int."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576915302174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576915302174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T06:29:28Z","timestamp":1718260168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576915302174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":23,"alternative-id":["S1567576915302174"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2015.12.011","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of interleukin-23 as a biomarker in rheumatoid arthritis patients and its correlation with disease activity","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2015.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}